{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
Result display time: 30 min
Sensitivity: 99 %
The Alere NMP22® BladderChek® Test is a fast, easy to use and non-invasive test that aids in the diagnosis and monitoring of bladder cancer, in conjunction with standard ...
Result display time: 90 min
Specificity: 84.6 %
Sensitivity: 75.8, 52.2, 88.4 %
... common symptom of bladder cancer.3 4 out of 5 people with bladder cancer have some blood in their urine4, however: 80–90% patients with gross haematuria do NOT have ...
Cepheid
Result display time: 90 min
In Europe 415,000 people live with bladder cancer.1 The 5-year survival rates for patients diagnosed with non-muscle invasive bladder cancer (NMIBC) are very good (~93%). ...
Cepheid
A Rapid Test For the Qualitative Detection of Bladder Tumor Associated Antigen in Human Urine CLIA Waived Indicated for the use as an aid in the monitoring of bladder ...
Result display time: 10 min
Sample volume: 0.5 ml
... yourself Product description Quantitative rapid test for bladder cancer diagnosis For patients at high risk of bladder cancer, ...
... stages of the disease. UBC® is available in Rapid, ELISA and IRMA format. UBC® Rapid is a powerful Doctors-office test (Point-of-Care), for both primary diagnosis ...
Please specify:
Help us improve:
remaining